Innovative Eyewear Inc. Common Stock (LUCY)
Stock · NASDAQ · Health Care
$0.8114as of 10/16/2026
Price chart
Active signals
LUCY Signal Track Record
How signals performed across all stocks →What LUCY's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 26 | -12.6% | 15% | August 24, 2026 |
| Bollinger Band BreakdownActive now | 19 | -10.7% | 21% | June 22, 2026 |
| Bollinger Band Breakout | 11 | -15.3% | 18% | August 24, 2026 |
| 200-Day Moving Average TouchActive now | 4 | -9.4% | 0% | August 24, 2026 |
| Any 20-session window (baseline) | -8.9% | 25% |
Computed by MarketWall from daily closing prices since May 31, 2023. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About LUCY
Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names. The company a…
- Sector
- Health Care
- Industry
- Ophthalmic Goods
- Employees
- 13
- Website
- lucyd.co/
Fundamentals
- 1-day range
- $0.83$0.8675
- Market cap
- $6.19M
- P/E (trailing)
- —
- P/E (forward)
- -2.01
- EPS (trailing)
- $-1.35
- Dividend yield
- —
- Beta
- 2.88
- Avg. volume
- 3.54M
How Innovative Eyewear Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 25, 2026 · via SEC EDGAR / Finnhub
Innovative Eyewear Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- LUCYInnovative Eyewear Inc. Common Stock$0.79▼ 6.29%Market cap $6.19MP/E —$0.65$2.05
- LUCYWInnovative Eyewear Inc. Series A Warrants 8/16/27$0.0251▼ 10.36%Market cap $556.8KP/E —$0.0251$0.152
- RXSTRxSight Inc. Common Stock$4.51▼ 3.43%Market cap $251.69MP/E —$4.4$13.22
- STAASTAAR Surgical Company Common Stock$21.27▼ 4.45%Market cap $1.15BP/E 288.93$15.59$35.87
- EYENational Vision Holdings Inc. Common Stock$17.43▼ 1.30%Market cap $1.80BP/E 27.65$14.75$30.02
- WRBYWarby Parker Inc. Class A Common Stock$23.34▼ 5.08%Market cap $3.31BP/E 365.43$14.96$31
- BLCOBausch + Lomb Corporation Common Shares$16.49▼ 1.02%Market cap $5.84BP/E —$14.44$18.92
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| LUCY Innovative Eyewear Inc. Common Stock | $6.19M | — | $0.79 | ▼ 6.29% | $0.65$2.05 |
| LUCYW Innovative Eyewear Inc. Series A Warrants 8/16/27 | $556.8K | — | $0.0251 | ▼ 10.36% | $0.0251$0.152 |
| RXST RxSight Inc. Common Stock | $251.69M | — | $4.51 | ▼ 3.43% | $4.4$13.22 |
| STAA STAAR Surgical Company Common Stock | $1.15B | 288.93 | $21.27 | ▼ 4.45% | $15.59$35.87 |
| EYE National Vision Holdings Inc. Common Stock | $1.80B | 27.65 | $17.43 | ▼ 1.30% | $14.75$30.02 |
| WRBY Warby Parker Inc. Class A Common Stock | $3.31B | 365.43 | $23.34 | ▼ 5.08% | $14.96$31 |
| BLCO Bausch + Lomb Corporation Common Shares | $5.84B | — | $16.49 | ▼ 1.02% | $14.44$18.92 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Innovative Eyewear Says It Received Nasdaq Minimum Bid Price Deficiency Notice; Has Until April 7, 2027 To Regain Compliancebenzinga · 10/15/2026
- Innovative Eyewear, Inc. Launches Lucyd AeroYahoo · 10/8/2026
- Innovative Eyewear Introduces Lucyd Aero Smart Eyewear CollectionBenzinga · 10/8/2026
- Innovative Eyewear Reports Record Preliminary Q3 2026 Net Sales, Up 55% Year-Over-YearYahoo · 10/6/2026
- Innovative Eyewear Reports Preliminary Q3 2026 Net Sales Of ~$1.04M, Up 55% Over Q3 2025Benzinga · 10/6/2026
Insider Activity
Insider Actions →- Gayle Oswald · August 19, 2026 · Sale8.0K @ $0.6745
- Gayle Oswald · August 19, 2026 · Grant16.2K
- Dabrowski Konrad · August 19, 2026 · Sale6.9K @ $0.6911
- Dabrowski Konrad · August 19, 2026 · Grant20.9K
- Abondano Joaquin · August 19, 2026 · Sale5.0K @ $0.6765
- Abondano Joaquin · August 19, 2026 · Grant14.8K
- Gross Harrison R. · August 19, 2026 · Sale5.7K @ $0.705
- Gross Harrison R. · August 19, 2026 · Sale8.3K @ $0.6916
- Gross Harrison R. · August 19, 2026 · Grant24.6K
- Cohen David Eric · August 19, 2026 · Sale6.1K @ $0.6802
- Cohen David Eric · August 19, 2026 · Grant18.2K
- Cohen David Eric · July 6, 2026 · Sale1.9K @ $1.17
Institutional Ownership
March 31, 2026
- Total shares held
- 578.2K
- Total value held
- $629.6K
- Institutional holders
- 7
- Unknown500.0K
- Unknown60.5K
- Unknown15.0K
- Unknown1.8K
- Unknown614
- Unknown300
- Unknown1
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Innovative Eyewear Q3 2026 Sales Rise 55%
Innovative Eyewear announced preliminary Q3 2026 net sales of about $1.04 million, a 55 % increase from the same period in 2025. The rise in revenue may support the stock’s current trading near its $1.02 support level. The company’s RSI of 53.0 indicates neither overbought nor oversold conditions. The 52‑week range remains $0.65 to $2.08.
Innovative Eyewear Q3 2026 Sales Rise 55%. Innovative Eyewear announced preliminary Q3 2026 net sales of about $1.04 million, a 55 % increase from the same period in 2025. The rise in revenue may support the stock’s current trading near its $1.02 support level. The company’s RSI of 53.0 indicates neither overbought nor oversold conditions. The 52‑week range remains $0.65 to $2.08.